Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin vs MTA in Pulpotomy of Immature Permanent Molars
NCT05878158Phase 1Unknown
- Start
- Apr 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of simvastatin in reversible pulpitis (2 arms). Primary endpoint: Presence or absence of pain at 1 year. Status: unknown.
02
Drugs
simvastatin
03
Conditions
reversible pulpitis
Beyond the preview
Go deeper on NCT05878158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05878158.